JP2020523375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020523375A5 JP2020523375A5 JP2019569250A JP2019569250A JP2020523375A5 JP 2020523375 A5 JP2020523375 A5 JP 2020523375A5 JP 2019569250 A JP2019569250 A JP 2019569250A JP 2019569250 A JP2019569250 A JP 2019569250A JP 2020523375 A5 JP2020523375 A5 JP 2020523375A5
- Authority
- JP
- Japan
- Prior art keywords
- selenium
- use according
- fish oil
- amount
- hyperthermia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 9
- 229910052711 selenium Inorganic materials 0.000 claims 9
- 239000011669 selenium Substances 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 8
- 235000021323 fish oil Nutrition 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 206010020843 Hyperthermia Diseases 0.000 claims 4
- 230000036031 hyperthermia Effects 0.000 claims 4
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 210000004460 N cell Anatomy 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000001235 sensitizing effect Effects 0.000 claims 1
- 230000002195 synergetic effect Effects 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023093883A JP2023105154A (ja) | 2017-06-13 | 2023-06-07 | がん細胞のｐＡＭＰＫαまたはＣＯＸ－２の含有量を調節するための薬剤の調製のための増感剤の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762519090P | 2017-06-13 | 2017-06-13 | |
| US62/519,090 | 2017-06-13 | ||
| PCT/US2018/037268 WO2018231938A1 (en) | 2017-06-13 | 2018-06-13 | Compositions and methods for enhancing hyperthermia therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023093883A Division JP2023105154A (ja) | 2017-06-13 | 2023-06-07 | がん細胞のｐＡＭＰＫαまたはＣＯＸ－２の含有量を調節するための薬剤の調製のための増感剤の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523375A JP2020523375A (ja) | 2020-08-06 |
| JP2020523375A5 true JP2020523375A5 (enExample) | 2021-07-26 |
| JP7336994B2 JP7336994B2 (ja) | 2023-09-01 |
Family
ID=64562472
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569250A Active JP7336994B2 (ja) | 2017-06-13 | 2018-06-13 | 温熱療法治療を増強するための組成物および方法 |
| JP2023093883A Pending JP2023105154A (ja) | 2017-06-13 | 2023-06-07 | がん細胞のｐＡＭＰＫαまたはＣＯＸ－２の含有量を調節するための薬剤の調製のための増感剤の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023093883A Pending JP2023105154A (ja) | 2017-06-13 | 2023-06-07 | がん細胞のｐＡＭＰＫαまたはＣＯＸ－２の含有量を調節するための薬剤の調製のための増感剤の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10905724B2 (enExample) |
| EP (1) | EP3638270B1 (enExample) |
| JP (2) | JP7336994B2 (enExample) |
| KR (1) | KR102773006B1 (enExample) |
| CN (2) | CN120695037A (enExample) |
| CA (1) | CA3066742A1 (enExample) |
| IL (1) | IL271327B2 (enExample) |
| TW (1) | TWI823853B (enExample) |
| WO (1) | WO2018231938A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11206861B2 (en) * | 2016-10-03 | 2021-12-28 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
| TWI823853B (zh) | 2017-06-13 | 2023-12-01 | 夏滉 | 敏化劑用於製備藥物的用途 |
| KR20220003528A (ko) * | 2019-04-01 | 2022-01-10 | 호운 사이먼 샤 | 암 면역요법을 위한 조성물 및 방법 |
| US20210393579A1 (en) * | 2020-06-23 | 2021-12-23 | Zestt Wellness Limited | Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health |
| CN115462488B (zh) * | 2022-10-08 | 2024-01-16 | 河南师范大学 | 鞣花酸作为饲料添加剂的应用，功能性饲料及制备方法 |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US988092A (en) * | 1909-11-22 | 1911-03-28 | Celfor Tool Company | Drill. |
| US4348483A (en) | 1981-01-23 | 1982-09-07 | Universal Foods Corporation | Method for the production of chromium yeast |
| US4569836A (en) * | 1981-08-27 | 1986-02-11 | Gordon Robert T | Cancer treatment by intracellular hyperthermia |
| CA2010511A1 (en) * | 1989-03-01 | 1990-09-01 | Roberto L. Ceriani | Method of enhancing cancer therapy by administration of unsaturated fatty acids |
| NZ248605A (en) | 1993-05-28 | 1994-12-22 | Abbott Lab | Enteral nutritional product comprising protein and fat |
| US20020010144A1 (en) | 1994-04-29 | 2002-01-24 | Robert Sobol | Enhancing the sensitivity of tumor cells to therapies |
| US5976548A (en) | 1994-11-08 | 1999-11-02 | Viva America Marketing, Inc. | Nutritional supplement composition and use |
| US6077828A (en) | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| US6440464B1 (en) | 1996-06-10 | 2002-08-27 | Viva Life Science | Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates |
| US6197295B1 (en) | 1996-09-25 | 2001-03-06 | Viva America Marketing Corporation | Dietary supplementation with, and methods for administration of yeast-derived selenium product |
| US5810888A (en) | 1997-06-26 | 1998-09-22 | Massachusetts Institute Of Technology | Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery |
| EP1100517A1 (en) | 1998-08-04 | 2001-05-23 | John V. Kosbab | Nutrient and therapeutic compositions for the treatment of cancer |
| AU5319499A (en) * | 1999-07-22 | 2001-02-13 | Ivan L. Cameron | Fatty acids to minimize cancer therapy side effects |
| US7569551B2 (en) | 2000-02-25 | 2009-08-04 | The University Of British Columbia | Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides |
| EP1383573A4 (en) * | 2001-03-26 | 2005-09-14 | Ellen A Inc | METHOD AND DEVICE FOR THE TREATMENT OF ANGRYED TISSUE |
| US7731648B2 (en) | 2001-07-25 | 2010-06-08 | Aduro Biotech | Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
| US20050013875A1 (en) | 2001-10-25 | 2005-01-20 | Takeshi Kobayashi | Immunopotentiators in thermotherapy for cancer |
| US20040087490A1 (en) | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
| AU2002951833A0 (en) | 2002-10-02 | 2002-10-24 | Novogen Research Pty Ltd | Compositions and therapeutic methods invloving platinum complexes |
| US7744930B2 (en) | 2002-11-22 | 2010-06-29 | Shaklee Corporation | Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass |
| US8663679B2 (en) * | 2004-04-29 | 2014-03-04 | Abbott Laboratories | Compositions for improving breast health in women |
| US9107864B2 (en) * | 2004-06-07 | 2015-08-18 | Qu Biologics Inc. | Tissue targeted antigenic activation of the immune response to treat cancers |
| US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
| US20070116802A1 (en) | 2005-11-23 | 2007-05-24 | Carl Germano | High quality caloric composition |
| US8017147B2 (en) | 2008-04-07 | 2011-09-13 | Mazed Mohammad A | Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| US20090110674A1 (en) | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
| EP2242539B1 (en) | 2008-01-16 | 2015-04-01 | Nanospectra Biosciences, Inc. | Nanoparticles for focused hyperthermia to increase efficacy of radiation therapy |
| WO2009157759A1 (en) | 2008-06-23 | 2009-12-30 | N.V. Nutricia | Nutritional composition for improving the mammalian immune system |
| WO2010026638A1 (ja) | 2008-09-04 | 2010-03-11 | 株式会社ナノセラピー研究所 | 抗制御性ｔ細胞抗体と磁性微粒子を含む悪性腫瘍の温熱治療用キット、及びその温熱治療法 |
| AU2009293475A1 (en) | 2008-09-19 | 2010-03-25 | Nestec S.A. | Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| US8257694B2 (en) | 2009-05-14 | 2012-09-04 | Product Partners, Llc | Nutritional compositions for reducing oxidative damage |
| AU2010253968B2 (en) * | 2009-05-29 | 2016-07-28 | Board Of Regents Of The University Of Texas System | Compositions and methods for modulating lipid composition |
| KR101275724B1 (ko) | 2009-12-09 | 2013-06-17 | 한국전자통신연구원 | 단일 기판 집적 회로 장치 및 그 제조 방법 |
| WO2011094579A2 (en) | 2010-01-29 | 2011-08-04 | New Chapter Inc. | Mushroom compositions and methods for making and using |
| WO2011115062A1 (ja) | 2010-03-15 | 2011-09-22 | 国立大学法人 岡山大学 | 抗腫瘍作用補助剤 |
| US20120010688A1 (en) | 2010-07-09 | 2012-01-12 | Lamb Karl J | Implantable conductive element and method of use inhyperthermic treatment |
| WO2012018597A2 (en) * | 2010-07-26 | 2012-02-09 | Chemotherapeutics, Llc | Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments |
| WO2012018595A2 (en) | 2010-07-26 | 2012-02-09 | Laird Technologies, Inc. | Process for the fabrication of highly electrically- conductive polymer foams with controlled compression set suitable for use in emi shielding applications |
| US9642925B2 (en) | 2010-12-07 | 2017-05-09 | Sanford Research/USD | Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use |
| WO2012122295A2 (en) | 2011-03-07 | 2012-09-13 | Ned Biosystems, Inc. | Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin |
| CN102349699B (zh) | 2011-07-04 | 2013-07-03 | 郑俊祥 | 一种电子烟液的制备方法 |
| US9609457B2 (en) | 2012-07-27 | 2017-03-28 | Crexendo, Inc. | Mobile application procurement and configuration options for VOIP service |
| KR101868675B1 (ko) | 2012-10-05 | 2018-06-18 | 연세대학교 산학협력단 | 민감화 물질을 포함하는 온열 치료용 조성물 |
| US9072768B2 (en) | 2013-01-22 | 2015-07-07 | Kibow Biotech, Inc. | Composition and method for increasing effectiveness of radiation or chemotherapy |
| US9107947B2 (en) * | 2013-01-31 | 2015-08-18 | The Penn State Research Foundation | Anti-cancer compositions and methods |
| WO2014159851A2 (en) * | 2013-03-13 | 2014-10-02 | The Board Of Regents Of The University Of Texas System | Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer |
| DE202013002760U1 (de) | 2013-03-21 | 2014-06-23 | Cc Pharma Gmbh | Nahrungsergänzungsmittel zur medikationsorientierten Supplementierung |
| US20140294795A1 (en) * | 2013-03-28 | 2014-10-02 | Houn Simon Hsia | Nutritional Composition |
| ES2753387T3 (es) * | 2013-04-22 | 2020-04-08 | Smartfish As | Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer |
| JP2016531114A (ja) | 2013-07-31 | 2016-10-06 | 株式会社明治 | 腫瘍の成長を阻止する栄養組成物 |
| WO2015021936A1 (en) | 2013-08-16 | 2015-02-19 | The University Of Hong Kong | Method and compositions for treating cancer using probiotics cross-reference to related application |
| CN104082736A (zh) * | 2014-06-13 | 2014-10-08 | 胡安然 | 一种调理乳腺癌的方便食品 |
| US20170246136A1 (en) * | 2014-09-24 | 2017-08-31 | OliVentures, Inc. | Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases |
| CN105641000A (zh) * | 2015-06-01 | 2016-06-08 | 深圳市康道生物有限公司 | 一种含灰树花提取物的抗肿瘤组合物及其制备方法 |
| CN108472322A (zh) | 2015-11-18 | 2018-08-31 | 赛贝格咨询有限责任公司 | 含有天然提取物的组合物以及它们在皮肤和毛发中的用途 |
| CN105617358A (zh) * | 2015-12-29 | 2016-06-01 | 广州市戴菊科技发展有限公司 | 一种具有抗肿瘤功能的医用食品及其制备方法 |
| CN105768108A (zh) | 2016-03-10 | 2016-07-20 | 福格森（武汉）生物科技股份有限公司 | 一种适用于肿瘤患者服用的特膳食品 |
| JP6376186B2 (ja) | 2016-08-04 | 2018-08-22 | トヨタ自動車株式会社 | サスペンションメンバ |
| US11206861B2 (en) | 2016-10-03 | 2021-12-28 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
| CN106822560A (zh) | 2017-04-07 | 2017-06-13 | 湖北工程学院 | 药物组合物及其制备方法 |
| CN111556754A (zh) | 2017-06-13 | 2020-08-18 | 夏滉 | 增强癌症化学疗法的组合物和方法 |
| TWI823853B (zh) | 2017-06-13 | 2023-12-01 | 夏滉 | 敏化劑用於製備藥物的用途 |
| KR102775757B1 (ko) | 2017-06-13 | 2025-02-28 | 호운 사이먼 샤 | 암 방사선요법을 향상시키기 위한 조성물 및 방법 |
| JP2020121479A (ja) | 2019-01-30 | 2020-08-13 | オリンパス株式会社 | 射出成形金型 |
-
2018
- 2018-06-13 TW TW107120417A patent/TWI823853B/zh active
- 2018-06-13 WO PCT/US2018/037268 patent/WO2018231938A1/en not_active Ceased
- 2018-06-13 EP EP18817547.5A patent/EP3638270B1/en active Active
- 2018-06-13 KR KR1020207000881A patent/KR102773006B1/ko active Active
- 2018-06-13 JP JP2019569250A patent/JP7336994B2/ja active Active
- 2018-06-13 US US16/007,524 patent/US10905724B2/en active Active
- 2018-06-13 IL IL271327A patent/IL271327B2/en unknown
- 2018-06-13 CN CN202510222932.9A patent/CN120695037A/zh active Pending
- 2018-06-13 CN CN201880048905.2A patent/CN111479578A/zh active Pending
- 2018-06-13 CA CA3066742A patent/CA3066742A1/en active Pending
-
2021
- 2021-01-30 US US17/163,419 patent/US11433105B2/en active Active
-
2022
- 2022-07-27 US US17/874,540 patent/US11896624B2/en active Active
-
2023
- 2023-06-07 JP JP2023093883A patent/JP2023105154A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020523375A5 (enExample) | ||
| Takeishi et al. | To wake up cancer stem cells, or to let them sleep, that is the question | |
| Chen et al. | The role of dasatinib in the management of chronic myeloid leukemia | |
| Ajani et al. | Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial | |
| CN111065639A (zh) | 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途 | |
| Harrison et al. | Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy | |
| Chatran et al. | Synergistic anti-proliferative effects of metformin and silibinin combination on T47D breast cancer cells via hTERT and cyclin D1 inhibition | |
| Ahn et al. | Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma | |
| JP2016528162A5 (enExample) | ||
| Patel et al. | Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients | |
| Wu et al. | Efficacy and safety of pemetrexed/cisplatin versus gemcitabine/cisplatin as first-line treatment in Chinese patients with advanced nonsquamous non-small cell lung cancer | |
| JP2018511625A5 (enExample) | ||
| JP2016520528A5 (enExample) | ||
| Qi et al. | Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo | |
| Sharma et al. | Molecular aspects and therapeutic implications of herbal compounds targeting different types of cancer | |
| JP2019530706A5 (enExample) | ||
| Rosenthal et al. | A Phase Ib Study of the combination of Aurora Kinase Inhibitor alisertib (MLN8237) and bortezomib in Relapsed or Refractory Multiple Myeloma | |
| Dómine Gómez et al. | Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer | |
| ES2656913T3 (es) | Endrogenina A y agentes antineoplásicos para el tratamiento de tumores quimiosensibles o quimiorresistentes | |
| Maute et al. | Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis | |
| JP2021505669A5 (enExample) | ||
| Breithaupt et al. | Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients | |
| Fernandes et al. | A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer: a review of CDK inhibitors | |
| Sakiyama et al. | A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer | |
| Chaudhary et al. | A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer |